Skip to content
★ Sign in to follow
JK
Total declarations
8
Company
1
▲ Purchases (3 ops.)
€137k
▼ Sales (0 ops.)
—

Latest filing published 21 Jan 2011 for Angiodynamics INC, €113k.

Insider track record

Disclosed buys
3
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
3
Positive at T+90
100%
Median T+90
+2.4%

Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 23 Jul 2009 · 6318 days ago · €40k
    +33.7%
    Entry US$11.95 · Close at T+365 US$15.98
  • Filed 14 Apr 2009 · 6418 days ago · €51k
    +25.9%
    Entry US$12.71 · Close at T+365 US$16.00

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Jan Keltjens: trading record in brief

This profile gathers the share dealings of Jan Keltjens in Angiodynamics Inc. Over a trading history stretching from 19 January 2009 to 19 January 2011, the count stands at 8 filings.

No open-market sale appears; the market trades are 3 purchases worth €137k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 5 share grants.

The median purchase comes to €47k. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 100% of cases; the median change was +2.4%. This is a record of the past, not a forecast.

Most recently, on 21 January 2011, the filings show a share grant worth €113k in Angiodynamics Inc. The last insider purchase was made public on 23 July 2009, 6,318 days ago. The median gap between a trade and its publication by SEC (Form 4) is 34 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Jan Keltjens

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total
  • ◆
    President & CEOExecutivesAngiodynamics Inc
    150,597 USD0SEC
    9,094 shares@ US$16.56Common StockSEC:0001140361-11-003654:0
  • ◆
    President & CEOExecutivesAngiodynamics Inc
    0SEC
    90,000 shares0Common StockSEC:0001275187-10-000016:0
  • ◆
    President & CEOExecutivesAngiodynamics Inc
    0SEC
    20,000 shares0Common StockSEC:0001275187-10-000016:2
  • ◆
    President & CEOExecutivesAngiodynamics Inc
    140,326 USD0SEC
    8,149 shares@ US$17.22Common StockSEC:0001140361-10-017976:0
  • ▲
    President & CEOExecutivesAngiodynamics Inc
    56,250 USD0SEC
    5,000 shares@ US$11.25Common StockSEC:0001275187-09-000017:0
    Canonical exit: 19 Oct 2009 (T+90)
  • ▲
    President & CEOExecutivesAngiodynamics Inc
    65,000 USD0SEC
    5,000 shares@ US$13.00Common StockSEC:0001275187-09-000014:0
    Canonical exit: 12 May 2009 (T+90)
  • ▲
    President & CEOExecutivesAngiodynamics Inc
    62,350 USD0SEC
    5,000 shares@ US$12.47Common StockSEC:0001275187-09-000014:1
    Canonical exit: 8 Jul 2009 (T+90)

7 of 7 declarations